Distributors

EquiCord has chosen the Dômes Pharma Group to market the world's first injectable stem cell formula for the treatment of canine osteoarthritis.

The independent, family-owned Dômes Pharma group has been present in the pharmaceutical industry since 1947 and has 400 employees across five centers in France, England, and Germany. For over 75 years, the Group has been developing, manufacturing, and marketing solutions for pet health and well-being, and its products are currently distributed in more than 15 countries.